Related Experiment Video
Updated: Jul 16, 2026
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Expression of transforming growth factor-beta receptor type 1 and type 2 in human sporadic vestibular Schwannoma
Mathias Löttrich1, Christian Mawrin, Kathrin Chamaon
1Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.
Abstract:
Expression of the transforming growth factor-beta (TGF-beta) protein family in the peripheral nervous system is well established, but the role of their cognate receptors TGF-beta receptor type 1 (R1) and type 2 (R2) has been less well studied. TGF-beta plays an essential role in Schwann cell proliferation and differentiation, and is involved in neurotrophic effects of several neurotrophic substances. TGF-beta is also expressed in benign peripheral nervous system tumors such as vestibular schwannomas. In the present study, we aimed to detect TGF-beta R1 and R2 in a total of 40 sporadic vestibular schwannomas using immunohistochemistry, and correlated the findings to essential clinicopathologic data. TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA was further analyzed by RT-PCR in six vestibular schwannomas. TGF-beta R1 immunoexpression was found in about 95% of the tumors. TGF-beta R1 was equally present in Antoni A and Antoni B areas of the tumors. TGF-beta R2 was found immunohistochemically in 77%. In addition, all tumors showed strong expression of TGF-beta. No correlation between TGF-beta R1 or R2 expression and clinicopathologic parameters such as age, sex, clinical symptoms, growth pattern, and proliferation acitivity as measured by Ki-67 (MIB-1) staining was found. Moreover, all schwannomas studied contained TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA. Therefore, the TGF-beta/TGF-beta R1 and -R2 system is present in human schwannomas, but its biologic role for tumor development and growth remains unclear.
Insights
The transforming growth factor-beta (TGF-beta) signaling system, including its receptors R1 and R2, is present in vestibular schwannomas. However, its specific role in tumor development and growth remains undetermined.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cell signaling
Background:
- Transforming growth factor-beta (TGF-beta) is crucial for Schwann cell function in the peripheral nervous system.
- TGF-beta is implicated in neurotrophic effects and is found in benign tumors like vestibular schwannomas.
- The roles of TGF-beta receptors, TGF-beta receptor type 1 (R1) and type 2 (R2), in these tumors are not well understood.
Purpose of the Study:
- To investigate the expression and presence of TGF-beta R1 and R2 in sporadic vestibular schwannomas.
- To correlate the expression of TGF-beta R1 and R2 with clinicopathological data of the tumors.
- To determine if the TGF-beta signaling pathway is active at the mRNA level in these tumors.
Main Methods:
- Immunohistochemistry was used to detect TGF-beta R1 and R2 protein expression in 40 vestibular schwannomas.
- RT-PCR was employed to analyze TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA levels in six vestibular schwannomas.
- Clinicopathological parameters, including age, sex, symptoms, growth patterns, and Ki-67 staining, were correlated with receptor expression.
Main Results:
- TGF-beta R1 was detected in approximately 95% of tumors, present in both Antoni A and B areas.
- TGF-beta R2 was found in 77% of tumors, and strong TGF-beta expression was observed in all tumors.
- No significant correlation was found between TGF-beta R1 or R2 expression and the analyzed clinicopathological parameters.
- All analyzed schwannomas expressed TGF-beta, TGF-beta R1, and TGF-beta R2 mRNA.
Conclusions:
- The complete TGF-beta/TGF-beta R1/R2 signaling system is present in human vestibular schwannomas at both protein and mRNA levels.
- Despite its presence, the specific biological function of this system in the development and growth of vestibular schwannomas is currently unclear.
- Further research is needed to elucidate the precise role of TGF-beta signaling in schwannoma pathogenesis.
